⌘K

Login Start Free

Home/Filings/4/0001179110-13-017041

4//SEC Filing

OSIRIS THERAPEUTICS, INC. 4

Accession 0001179110-13-017041

CIK 0001360886operating

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 6:53 AM ET

Size

14.4 KB

Accession

0001179110-13-017041

Insider Transaction Report

Form 4

Period: 2013-11-25

OSIRIS THERAPEUTICS, INC.OSIR

JACOBY PHILIP R JR

Vice President of Finance

Transactions

Exercise/Conversion
Common Stock
2013-11-25$5.08/sh+4,999$25,395→ 30,872 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-11-25$5.08/sh−4,999$25,395→ 95,128 total
Exercise: $5.08From: 2013-03-23Exp: 2022-03-23→ Common Stock (4,999 underlying)
Exercise/Conversion
CommonStock
2013-11-25$6.46/sh+3,749$24,219→ 16,249 total
Exercise/Conversion
CommonStock
2013-11-25$7.13/sh+9,624$68,619→ 25,873 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-11-25$6.46/sh−3,749$24,219→ 109,751 total
Exercise: $6.46From: 2011-05-27Exp: 2020-05-27→ Common Stock (3,749 underlying)
Sale
Common Stock
2013-11-25$15.99/sh−18,372$293,680→ 12,500 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-11-25$7.13/sh−9,624$68,619→ 100,127 total
Exercise: $7.13From: 2012-02-14Exp: 2021-02-14→ Common Stock (9,624 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

Entity typeoperating

IncorporatedMD

Related Parties

1

filerCIK 0001360886

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 6:53 AM ET
Size: 14.4 KB

View on SEC.gov